HUNTSMAN ICI CHEMICALS LLC
10-Q, EX-27, 2000-08-11
CHEMICALS & ALLIED PRODUCTS
Previous: HUNTSMAN ICI CHEMICALS LLC, 10-Q, 2000-08-11
Next: ACE SECURITIES CORP HOME EQUITY LOAN TRUST 1999-LB1, 10-K/A, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>        5
<LEGEND>
                 This schedule contains summary financial information extracted
                 from the second quarter 10-Q and is qualified in its entirety
                 by reference to such 10-Q.
</LEGEND>
<MULTIPLIER>     1000

<S>                                  <C>                <C>             <C>                <C>
<PERIOD-TYPE>                        3-MOS              3-MOS           6-MOS              6-MOS
<FISCAL-YEAR-END>                    DEC-31-2000        DEC-31-1999     DEC-31-2000        DEC-31-1999
<PERIOD-START>                       MAR-31-2000        MAR-31-1999     JAN-01-2000        JAN-01-1999
<PERIOD-END>                         JUN-30-2000        JUN-30-1999     JUN-30-2000        JUN-30-1999
<CASH>                                         0                  0         122,200                  0
<SECURITIES>                                   0                  0               0                  0
<RECEIVABLES>                                  0                  0         690,600                  0
<ALLOWANCES>                                   0                  0           8,200                  0
<INVENTORY>                                    0                  0         383,500                  0
<CURRENT-ASSETS>                               0                  0       1,273,100                  0
<PP&E>                                         0                  0       2,864,100                  0
<DEPRECIATION>                                 0                  0         213,300                  0
<TOTAL-ASSETS>                                 0                  0       4,762,000                  0
<CURRENT-LIABILITIES>                          0                  0         799,300                  0
<BONDS>                                        0                  0       2,368,900                  0
<COMMON>                                       0                  0       1,026,100                  0
                          0                  0               0                  0
                                    0                  0               0                  0
<OTHER-SE>                                     0                  0          96,200                  0
<TOTAL-LIABILITY-AND-EQUITY>                   0                  0       4,762,000                  0
<SALES>                                1,146,600             93,400       2,189,300            163,000
<TOTAL-REVENUES>                       1,154,700            108,600       2,209,600            192,000
<CGS>                                    948,900             72,400       1,822,500            134,100
<TOTAL-COSTS>                          1,024,900             74,900       1,984,400            139,400
<OTHER-EXPENSES>                           1,300                  0           1,700                  0
<LOSS-PROVISION>                               0                  0               0                  0
<INTEREST-EXPENSE>                        55,200              8,900         111,100             18,300
<INCOME-PRETAX>                           73,800             25,000         114,500             34,500
<INCOME-TAX>                               9,000              9,500          12,900             13,100
<INCOME-CONTINUING>                       64,000             15,500         100,300             21,400
<DISCONTINUED>                                 0                  0               0                  0
<EXTRAORDINARY>                                0                  0               0                  0
<CHANGES>                                      0                  0               0                  0
<NET-INCOME>                              64,000             15,500         100,300             21,400
<EPS-BASIC>                                    0                  0               0                  0
<EPS-DILUTED>                                  0                  0               0                  0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission